SEC Comment Letter for MYRIAD GENETICS INC (MYGN) (CIK 0000899923) (MYGN) — Jul 23, 2008

MYRIAD GENETICS INC (MYGN) (CIK 0000899923)
Date: July 23, 2008 · CIK: 0000899923 · Accession: 0000000000-08-036666

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

July 23, 2008

Author

Accountant

Form

UPLOAD

Company

MYRIAD GENETICS INC (MYGN) (CIK 0000899923)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 July 23, 2008 Mr. James S. Evans Chief Financial Officer Myriad Genetics, Inc. 320 Wakara Way Salt Lake City, UT 84108

Re: Myriad Genetics, Inc. Form 10-K for Fiscal Year Ended June 30, 2007 File No. 0-26642

Dear Mr. Evans:

We have completed our review of your Form 10-K and have no further comments at this time. Sincerely,

Jim B. Rosenberg Senior Assistant Chief Accountant

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010         July 23, 2008
Mr. James S. Evans
Chief Financial Officer
Myriad Genetics, Inc.
320 Wakara Way
Salt Lake City, UT  84108

Re: Myriad Genetics, Inc.
 Form 10-K for Fiscal Year Ended June 30, 2007
 File No. 0-26642

Dear Mr. Evans:

We have completed our review of your Form 10-K and have no further comments
at this time.
Sincerely,

Jim B. Rosenberg Senior Assistant Chief
Accountant

SecProbe.io